Patents Assigned to Oculus Innovative Sciences, Inc.
  • Publication number: 20170071980
    Abstract: Methods of using oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours in dental applications are provided. The ORP water solution can be administered to patients for the routine disinfection of the oral cavity as part of an on-going program of oral hygiene. The ORP water solution can further be used to irrigate and/or disinfect oral tissues and surfaces during dental procedures, oral surgery, or maxillo-facial surgery. Also, the ORP water solution can be administered to treat patients with damage to the oral tissues caused by disease or surgery.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventor: Hojabr Alimi
  • Publication number: 20170049813
    Abstract: Methods and products are provided for treating a wound or infection in a mammal or disinfecting a surface with a hypochlorous acid solution that has been activated by a catalyst. Additionally provided is a process for preparing an antimicrobial product that produces an activated hypochlorous acid solution for use as an antimicrobial.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventor: Robert NORTHEY
  • Patent number: 9498548
    Abstract: Methods of using oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours in dental applications are provided. The ORP water solution can be administered to patients for the routine disinfection of the oral cavity as part of an on-going program of oral hygiene. The ORP water solution can further be used to irrigate and/or disinfect oral tissues and surfaces during dental procedures, oral surgery, or maxillo-facial surgery. Also, the ORP water solution can be administered to treat patients with damage to the oral tissues caused by disease or surgery.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: November 22, 2016
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Hojabr Alimi
  • Patent number: 9486479
    Abstract: Methods and products are provided for treating a wound or infection in a mammal or disinfecting a surface with a hypochlorous acid solution that has been activated by a catalyst. Additionally provided is a process for preparing an antimicrobial product that produces an activated hypochlorous acid solution for use as an antimicrobial.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: November 8, 2016
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Robert Northey
  • Publication number: 20160120183
    Abstract: Disclosed is an antimicrobial solution comprising, consisting essentially of or consisting of (a) hypochlorous acid, (b) a divalent cation, (c) phosphate anion, and (d) water, as well as a process for its production. Also disclosed is a method of treating or preventing infection associated with abdominal surgery on a mammal, comprising use of the antimicrobial solution.
    Type: Application
    Filed: May 22, 2014
    Publication date: May 5, 2016
    Applicant: OCULUS INNOVATIVE SCIENCES, INC
    Inventor: Robert NORTHEY
  • Publication number: 20160045547
    Abstract: Provided is a method for preventing or treating sinusitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers. The ORP water solution can be administered alone or, e.g., in combination with one or more additional therapeutic agents.
    Type: Application
    Filed: October 27, 2015
    Publication date: February 18, 2016
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventor: Hojabr ALIMI
  • Patent number: 9259410
    Abstract: The invention provides a method of treating or preventing polycystic ovarian syndrome (PCOS) in a mammal, comprising administering chlorogenic acid and inositol in an amount effective to treat or prevent PCOS in the mammal. In an embodiment of the invention, the method further comprises administering L-cysteine to the mammal.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: February 16, 2016
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: James J. Schutz
  • Publication number: 20150306137
    Abstract: Provided is a method for preventing or treating inflammation and associated states (e.g. infection, hypersensitivity, pain) by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents.
    Type: Application
    Filed: July 7, 2015
    Publication date: October 29, 2015
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventors: Hojabr ALIMI, Andrés GUTIÉRREZ
  • Patent number: 9168318
    Abstract: Provided is an oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours and methods of using the solution. The present invention provides a method of preventing or treating a condition in a patient, which method comprises administering a therapeutically effective amount of the ORP water solution. Additionally provided is a method of treating impaired or damaged tissue, which method comprises contacting the tissue with a therapeutically effective amount of the ORP water solution. Further provided is a method of disinfecting a surface, which method comprises contacting the surface with an anti-infective amount of the ORP water solution.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: October 27, 2015
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Hojabr Alimi
  • Patent number: 9072726
    Abstract: Provided is a method for preventing or treating inflammation and associated states (e.g. infection, hypersensitivity, pain) by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: July 7, 2015
    Assignee: Oculus Innovative Sciences, Inc.
    Inventors: Hojabr Alimi, Andrés Gutiérrez
  • Patent number: 8840873
    Abstract: A method of treating burns, preferably second and third degree burns, by administration of an oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours is provided.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: September 23, 2014
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Hojabr Alimi
  • Patent number: 8834445
    Abstract: Provided is a method for treating or preventing peritonitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents. Further provided is a method for preventing peritoneal hemorrhage, adhesions and abscesses.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: September 16, 2014
    Assignee: Oculus Innovative Sciences, Inc.
    Inventors: Hojabr Alimi, Andres Gutierrez
  • Patent number: 8784900
    Abstract: Methods and products are provided for treating a wound or infection in a mammal or disinfecting a surface with a hypochlorous acid solution that has been activated by a catalyst. Additionally provided is a process for preparing an antimicrobial product that produces an activated hypochlorous acid solution for use as an antimicrobial.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: July 22, 2014
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Robert Northey
  • Patent number: 8323252
    Abstract: Provided is a method of treating skin ulcers and related complications in patients by administering an oxidative reduction potential (ORP) water solution that is stable for at least twenty-four hours.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: December 4, 2012
    Assignee: Oculus Innovative Sciences, Inc.
    Inventors: Hojabr Alimi, Andres Gutierrez
  • Publication number: 20120269904
    Abstract: The present invention relates to low pH antimicrobial solutions comprising hypochlorous acid, water, and, optionally, a buffer. The inventive low pH antimicrobial solutions have a pH from about 4 to about 6 and are useful for treating impaired or damaged tissue and for disinfecting surfaces. Chemical processes for the production of the low pH antimicrobial solutions are also provided wherein chlorine gas is added to a buffer solution containing a buffering agent and water. The present invention also provides an electrochemical process for the production of the low pH antimicrobial solutions.
    Type: Application
    Filed: June 15, 2010
    Publication date: October 25, 2012
    Applicant: Oculus Innovative Sciences, Inc.
    Inventor: Robert Northey
  • Publication number: 20120251631
    Abstract: Provided is a method for treating or preventing peritonitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents. Further provided is a method for preventing peritoneal hemorrhage, adhesions and abscesses.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 4, 2012
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventors: Hojabr ALIMI, Andres Gutierrez
  • Publication number: 20120207853
    Abstract: The present invention provides methods of treating, reducing, and/or preventing the incidence of an influenza related viral infection in a patient comprising administering a therapeutically effective amount of an oxidative reductive potential (ORP) water solution. The present invention also provides methods of reducing or preventing the incidence of an influenza related viral infection in a patient associated with a medical device comprising contacting the medical device with an effective amount of an ORP water solution.
    Type: Application
    Filed: May 10, 2010
    Publication date: August 16, 2012
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventors: Hojabr Alimi, Eileen Thatcher
  • Publication number: 20120164235
    Abstract: The present invention relates to a hydrogel formulation containing an oxidative reduction potential (ORP) water solution and a gelling agent. The invention further provides a method for treating or preventing a condition in a patient comprising topically administering to a patient a therapeutically effective amount of a hydrogel formulation comprising an oxidative reductive potential solution and a gelling agent. A method for promoting wound healing in a patient is also provided.
    Type: Application
    Filed: July 30, 2010
    Publication date: June 28, 2012
    Applicant: OCULUS INNOVATIVE SCIENCES, INC.
    Inventor: Robert Northey
  • Patent number: 8147444
    Abstract: Provided is a method for treating or preventing peritonitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers and can be administered in conjunction with one or more additional therapeutic agents. Further provided is a method for preventing peritoneal hemorrhage, adhesions and abscesses.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: April 3, 2012
    Assignee: Oculus Innovative Sciences, Inc.
    Inventors: Hojabr Alimi, Andrés Gutiérrez
  • Patent number: 8062500
    Abstract: A method and apparatus for electrolytically producing oxidation reduction potential water from aqueous salt solutions for use in disinfection, sterilization, decontamination, wound cleansing. The apparatus includes an electrolysis unit having a three-compartment cell (22) comprising a cathode chamber (18), an anode chamber (16), and a saline solution chamber (20) interposed between the anode and cathode chambers. Two communicating (24, 26) membranes separate the three chambers. The center chamber includes a fluid flow inlet (21a) and outlet (21b) and contains insulative material that ensures direct voltage potential does not travel through the chamber. A supply of water flows through the cathode and anode chambers at the respective sides of the saline chamber. Saline solution flows through the center chamber, either by circulating a pre-prepared aqueous solution containing ionic species, or, alternatively, by circulating pure water or an aqueous solution of, e.g.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: November 22, 2011
    Assignee: Oculus Innovative Sciences, Inc.
    Inventor: Osao Sumita